GD Schmith

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Longitudinal dose-response analyses of alitretinoin (an investigational agent in the US) were conducted to supplement results from phase III studies in severe, refractory chronic hand eczema, with objectives to address several outstanding development issues (e.g., optimal dose, possible factors affecting efficacy and/or tolerability). Models were fitted to(More)
  • 1